vs
RHYTHM PHARMACEUTICALS, INC.（RYTM）与TELOS CORP（TLS）财务数据对比。点击上方公司名可切换其他公司
RHYTHM PHARMACEUTICALS, INC.的季度营收约是TELOS CORP的1.2倍（$57.3M vs $46.8M），TELOS CORP净利率更高（-34.9% vs -83.0%，领先48.1%），TELOS CORP同比增速更快（77.4% vs 36.9%），过去两年RHYTHM PHARMACEUTICALS, INC.的营收复合增速更高（48.5% vs 25.7%）
Rhythm Pharmaceuticals是一家专注于罕见病领域的生物制药企业，主要开发和商业化针对罕见遗传性肥胖症的靶向疗法，覆盖POMC缺陷、LEPR缺陷、巴德-毕德氏综合征等适应症，服务北美、欧洲地区缺少有效治疗方案的患者群体。
泰洛斯公司（Telos Corporation）是一家信息技术与网络安全企业，总部位于美国弗吉尼亚州阿什本。公司主要服务对象为政府与企业客户，业务合同大部分来自美国国防部，核心客户涵盖美国军方、情报机构、民政部门以及北约盟友机构。
RYTM vs TLS — 直观对比
营收规模更大
RYTM
是对方的1.2倍
$46.8M
营收增速更快
TLS
高出40.5%
36.9%
净利率更高
TLS
高出48.1%
-83.0%
两年增速更快
RYTM
近两年复合增速
25.7%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $57.3M | $46.8M |
| 净利润 | $-47.5M | $-16.3M |
| 毛利率 | 91.6% | 35.0% |
| 营业利润率 | -82.2% | -39.6% |
| 净利率 | -83.0% | -34.9% |
| 营收同比 | 36.9% | 77.4% |
| 净利润同比 | -9.6% | -74.8% |
| 每股收益（稀释后） | $-0.73 | $-0.22 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收RYTMTLS
| Q4 25 | $57.3M | $46.8M | ||
| Q3 25 | $51.3M | $51.4M | ||
| Q2 25 | $48.5M | $36.0M | ||
| Q1 25 | $32.7M | $30.6M | ||
| Q4 24 | $41.8M | $26.4M | ||
| Q3 24 | $33.3M | $23.8M | ||
| Q2 24 | $29.1M | $28.5M | ||
| Q1 24 | $26.0M | $29.6M |
净利润RYTMTLS
| Q4 25 | $-47.5M | $-16.3M | ||
| Q3 25 | $-52.9M | $-2.1M | ||
| Q2 25 | $-46.6M | $-9.5M | ||
| Q1 25 | $-49.5M | $-8.6M | ||
| Q4 24 | $-43.3M | $-9.3M | ||
| Q3 24 | $-43.6M | $-28.1M | ||
| Q2 24 | $-32.3M | $-7.8M | ||
| Q1 24 | $-141.4M | $-7.4M |
毛利率RYTMTLS
| Q4 25 | 91.6% | 35.0% | ||
| Q3 25 | 89.3% | 39.9% | ||
| Q2 25 | 88.6% | 33.2% | ||
| Q1 25 | 88.8% | 39.8% | ||
| Q4 24 | 90.9% | 40.3% | ||
| Q3 24 | 88.5% | 13.2% | ||
| Q2 24 | 89.9% | 34.1% | ||
| Q1 24 | 89.2% | 37.0% |
营业利润率RYTMTLS
| Q4 25 | -82.2% | -39.6% | ||
| Q3 25 | -102.6% | -4.8% | ||
| Q2 25 | -93.4% | -27.5% | ||
| Q1 25 | -143.7% | -29.5% | ||
| Q4 24 | -98.6% | -37.6% | ||
| Q3 24 | -132.0% | -121.4% | ||
| Q2 24 | -139.2% | -30.3% | ||
| Q1 24 | -538.7% | -28.5% |
净利率RYTMTLS
| Q4 25 | -83.0% | -34.9% | ||
| Q3 25 | -103.1% | -4.1% | ||
| Q2 25 | -96.1% | -26.5% | ||
| Q1 25 | -151.4% | -28.1% | ||
| Q4 24 | -103.6% | -35.4% | ||
| Q3 24 | -131.2% | -118.0% | ||
| Q2 24 | -110.9% | -27.2% | ||
| Q1 24 | -544.4% | -24.9% |
每股收益（稀释后）RYTMTLS
| Q4 25 | $-0.73 | $-0.22 | ||
| Q3 25 | $-0.82 | $-0.03 | ||
| Q2 25 | $-0.75 | $-0.13 | ||
| Q1 25 | $-0.81 | $-0.12 | ||
| Q4 24 | $-0.71 | $-0.13 | ||
| Q3 24 | $-0.73 | $-0.39 | ||
| Q2 24 | $-0.55 | $-0.11 | ||
| Q1 24 | $-2.35 | $-0.10 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $388.9M | $53.2M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $139.1M | $96.0M |
| 总资产 | $480.2M | $139.9M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资RYTMTLS
| Q4 25 | $388.9M | $53.2M | ||
| Q3 25 | $416.1M | $59.0M | ||
| Q2 25 | $291.0M | $57.0M | ||
| Q1 25 | $314.5M | $57.8M | ||
| Q4 24 | $320.6M | $54.6M | ||
| Q3 24 | $298.4M | $69.8M | ||
| Q2 24 | $319.1M | $80.1M | ||
| Q1 24 | $201.2M | $93.9M |
股东权益RYTMTLS
| Q4 25 | $139.1M | $96.0M | ||
| Q3 25 | $148.8M | $119.7M | ||
| Q2 25 | $-11.9M | $118.4M | ||
| Q1 25 | $18.9M | $126.1M | ||
| Q4 24 | $21.7M | $127.1M | ||
| Q3 24 | $11.2M | $129.5M | ||
| Q2 24 | $39.3M | $149.1M | ||
| Q1 24 | $61.6M | $154.4M |
总资产RYTMTLS
| Q4 25 | $480.2M | $139.9M | ||
| Q3 25 | $506.9M | $164.3M | ||
| Q2 25 | $372.7M | $165.0M | ||
| Q1 25 | $386.7M | $158.1M | ||
| Q4 24 | $392.3M | $158.2M | ||
| Q3 24 | $363.6M | $166.3M | ||
| Q2 24 | $381.8M | $182.4M | ||
| Q1 24 | $258.7M | $195.4M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-25.4M | $8.0M |
| 自由现金流经营现金流 - 资本支出 | — | $8.0M |
| 自由现金流率自由现金流/营收 | — | 17.0% |
| 资本支出强度资本支出/营收 | — | 0.1% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $29.4M |
8季度趋势，按日历期对齐
经营现金流RYTMTLS
| Q4 25 | $-25.4M | $8.0M | ||
| Q3 25 | $-26.6M | $9.1M | ||
| Q2 25 | $-23.3M | $7.0M | ||
| Q1 25 | $-40.4M | $6.1M | ||
| Q4 24 | $-18.8M | $-10.5M | ||
| Q3 24 | $-25.2M | $-7.1M | ||
| Q2 24 | $-29.1M | $-8.0M | ||
| Q1 24 | $-40.7M | $-350.0K |
自由现金流RYTMTLS
| Q4 25 | — | $8.0M | ||
| Q3 25 | — | $8.7M | ||
| Q2 25 | — | $6.8M | ||
| Q1 25 | — | $6.0M | ||
| Q4 24 | — | $-12.4M | ||
| Q3 24 | — | $-7.1M | ||
| Q2 24 | — | $-8.2M | ||
| Q1 24 | — | $-447.0K |
自由现金流率RYTMTLS
| Q4 25 | — | 17.0% | ||
| Q3 25 | — | 16.9% | ||
| Q2 25 | — | 19.0% | ||
| Q1 25 | — | 19.5% | ||
| Q4 24 | — | -47.0% | ||
| Q3 24 | — | -30.0% | ||
| Q2 24 | — | -28.9% | ||
| Q1 24 | — | -1.5% |
资本支出强度RYTMTLS
| Q4 25 | — | 0.1% | ||
| Q3 25 | — | 0.9% | ||
| Q2 25 | — | 0.4% | ||
| Q1 25 | — | 0.4% | ||
| Q4 24 | — | 7.1% | ||
| Q3 24 | — | 0.2% | ||
| Q2 24 | — | 0.8% | ||
| Q1 24 | — | 0.3% |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
RYTM
暂无分部数据
TLS
| Security Solutions Segment | $44.8M | 96% |
| Secure Networks Segment | $1.9M | 4% |
